|
|
|
|
|
|
|
⋅ | Raised $2 million in equity investment in the Company in the form of private placements of common shares to accredited investors. Funds have been used to fund current operations; |
⋅ | Raised $2.5 million in investment in the Company in the form of secured debt. Funds have been used to re-finance higher interest rate secured debt, the expansion of our operations and to fund current operations; |
⋅ | Established a joint venture with Renaissance Diamonds, Inc. focused on the creation of recipes and procedures to develop, market, and sell lab-grown fancy-colored diamonds; and |
⋅ | Enhanced efforts on expanding and optimizing production of existing manufacturing capabilities. |
| | March 31, | | ||
| | 2015 | | 2014 | |
Common stock options and warrants | | 5,799,295 | | 9,609,295 | |
| | March 31, | | March 31, | | ||
| | 2015 | | 2014 | | ||
Raw materials and supplies | | $ | 58,390 | | $ | 35,543 | |
Work in process | | | 31,371 | | | 25,611 | |
Finished goods | | | 205,999 | | | 91,663 | |
| | $ | 295,760 | | $ | 152,817 | |
| | Years | |
Machinery and equipment | | 315 | |
Furniture and fixtures | | 310 | |
Engineering equipment | | 512 | |
|
| | | | March 31, | | March 31, | | ||
| | Life | | 2015 | | 2014 | | ||
Patents, gross | | 6.75 19.46 | | $ | 8,135,063 | | $ | 8,135,063 | |
In-process research and development | | Indefinite | | | 1,832,370 | | | 2,250,435 | |
| | | | | 9,967,433 | | | 10,385,498 | |
Accumulated amortization | | | | | (1,919,485) | | | (1,144,858) | |
Net intangible assets | | | | $ | 8,047,948 | | $ | 9,240,640 | |
Fiscal Year Ending | | | | |
March 31, 2016 | | $ | 774,840 | |
March 31, 2017 | | | 774,840 | |
March 31, 2018 | | | 774,840 | |
March 31, 2019 | | | 774,840 | |
March 31, 2020 | | | 595,159 | |
Thereafter | | $ | 2,521,059 | |
|
|
|
| | | | Weighted- | | Weighted-Average | | |
| | | | Average Exercise | | Remaining | | |
Options | | Shares | | Price | | Contractual Term | | |
Options Outstanding April 1, 2013 | | 4,092,500 | | $ | 0.87 | | 2.29 | |
Granted | | 706,250 | | | 0.36 | | | |
Exercised | | | | | | | | |
Expired/Cancelled | | (456,250) | | | 0.73 | | | |
Options Outstanding March 31, 2014 | | 4,342,500 | | $ | 0.77 | | 1.75 | |
Granted | | | | | | | | |
Exercised | | | | | | | | |
Expired/cancelled | | (4,110,000) | | | 0.79 | | | |
Options Outstanding March 31, 2015 | | 232,500 | | $ | 0.35 | | 1.45 | |
Exercisable at March 31, 2015 | | 23,125 | | $ | 0.44 | | 1.20 | |
| | | | Weighted Average | | |
| | | | Grant-Date | | |
Non-vested Shares | | Shares | | Fair Value | | |
Non-vested at April 1, 2013 | | 2,466,167 | | $ | 0.65 | |
Granted | | 706,250 | | | 0.22 | |
Vested | | (575,625) | | | 0.45 | |
Expired/cancelled: non-vested | | (182,000) | | | 0.38 | |
Non-vested at March 31, 2014 | | 2,414,792 | | | 0.49 | |
Granted | | | | | | |
Vested | | (122,000) | | | 0.43 | |
Expired/cancelled: non-vested | | (2,083,417) | | | 0.52 | |
Non-vested at March 31, 2015 | | 209,375 | | $ | 0.21 | |
| | | Options Outstanding | | Options Exercisable | | ||||||||
Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (years) | | Weighted Average Exercise Price | | Number of Shares | | Weighted Average Exercise Price | | |||
$ | 0.80 | | 7,500 | | 0.27 | | $ | 0.80 | | 5,500 | | $ | 0.80 | |
$ | 0.33 | | 225,000 | | 1.49 | | | 0.33 | | 17,625 | | | 0.33 | |
| | | 232,500 | | 1.45 | | $ | 0.35 | | 23,125 | | $ | 0.44 | |
|
|
2016 | | $ | 407,410 | |
2017 | | | 361,660 | |
2018 | | | 224,410 | |
2019 | | | 224,410 | |
2020 | | | | |
2021 and thereafter | | $ | | |
|
|
| | At March 31, | | At March 31, | | ||
| | 2015 | | 2014 | | ||
Accrued expenses | | $ | 194,165 | | $ | 235,998 | |
Property and equipment | | | (185,992) | | | (150,810) | |
Impairment of fixed assets | | | 299,537 | | | 142,767 | |
Capitalized startup/acquisition costs | | | 461,636 | | | 499,288 | |
Federal and state net operating loss carry-forward | | | 5,344,982 | | | 3,857,269 | |
Intangible assets | | | 59,849 | | | 14,537 | |
| | $ | 6,174,177 | | $ | 4,599,049 | |
| | | | | | | |
Valuation allowance | | | (6,174,177) | | | (4,599,049) | |
Total | | $ | | | $ | | |
| | At March 31, 2015 | | | At March 31, 2014 | | ||||||
| | Amount | | % | | | Amount | | % | | ||
Tax at statutory federal income tax rate | | $ | (1,408,162) | | (34.0) | % | | $ | (1,683,324) | | (34.0) | % |
Increase (decrease) resulting from: | | | | | | | | | | | | |
State income tax expense | | | | | 0.0 | % | | | | | 0.0 | % |
Change in valuation allowance | | | 1,406,400 | | 34.0 | % | | | 1,671,941 | | 33.8 | % |
Incentive stock options | | | | | 0.0 | % | | | | | 0.0 | % |
Other, net | | | 1,762 | | 0.0 | % | | | 11,383 | | 0.2 | % |
| | | | | | | | | | | | |
Total | | $ | | | 0.0 | % | | $ | | | 0.0 | % |
|
|
Balance of ownership interest in joint venture at December 18, 2014 | | $ | 1,000 | |
Aggregate fiscal 2014 equity gain share of joint venture income | | | 29,041 | |
Balance of ownership interest in joint venture at March 31, 2015 | | $ | 30,041 | |
| | | | |
Cumulative recognized income on ownership interest in joint venture at March 31, 2015 | | $ | 29,041 | |
Revenues | | $ | 124,908 | |
Expenses | | | 66,825 | |
Net Income | | $ | 58,083 | |
| | | | |
Total Assets | | $ | 551,405 | |
| | | | |
Total Liabilities | | $ | 491,322 | |
Total Partners Capital | | | 60,083 | |
Total Liabilities and Partner Capital | | $ | 551,405 | |
|
|
|
⋅ | Raised $2 million in equity investment in the Company in the form of private placements of common shares to accredited investors. Funds have been used to fund current operations; |
⋅ | Raised $2.5 million in investment in the Company in the form of secured debt. Funds have been used to re-finance higher interest rate secured debt, the expansion of our operations and to fund current operations; |
⋅ | Established a joint venture with Renaissance Diamonds, Inc. focused on the creation of recipes and procedures to develop, market, and sell lab-grown fancy-colored diamonds; and |
⋅ | Enhanced efforts on expanding and optimizing production of existing manufacturing capabilities. |
| | March 31, | | ||
| | 2015 | | 2014 | |
Common stock options and warrants | | 5,799,295 | | 9,609,295 | |
| | March 31, | | March 31, | | ||
| | 2015 | | 2014 | | ||
Raw materials and supplies | | $ | 58,390 | | $ | 35,543 | |
Work in process | | | 31,371 | | | 25,611 | |
Finished goods | | | 205,999 | | | 91,663 | |
| | $ | 295,760 | | $ | 152,817 | |
| | Years | |
Machinery and equipment | | 315 | |
Furniture and fixtures | | 310 | |
Engineering equipment | | 512 | |
|
| | March 31, | | ||
| | 2015 | | 2014 | |
Common stock options and warrants | | 5,799,295 | | 9,609,295 | |
| | March 31, | | March 31, | | ||
| | 2015 | | 2014 | | ||
Raw materials and supplies | | $ | 58,390 | | $ | 35,543 | |
Work in process | | | 31,371 | | | 25,611 | |
Finished goods | | | 205,999 | | | 91,663 | |
| | $ | 295,760 | | $ | 152,817 | |
| | Years | |
Machinery and equipment | | 315 | |
Furniture and fixtures | | 310 | |
Engineering equipment | | 512 | |
|
| | | | March 31, | | March 31, | | ||
| | Life | | 2015 | | 2014 | | ||
Patents, gross | | 6.75 19.46 | | $ | 8,135,063 | | $ | 8,135,063 | |
In-process research and development | | Indefinite | | | 1,832,370 | | | 2,250,435 | |
| | | | | 9,967,433 | | | 10,385,498 | |
Accumulated amortization | | | | | (1,919,485) | | | (1,144,858) | |
Net intangible assets | | | | $ | 8,047,948 | | $ | 9,240,640 | |
Fiscal Year Ending | | | | |
March 31, 2016 | | $ | 774,840 | |
March 31, 2017 | | | 774,840 | |
March 31, 2018 | | | 774,840 | |
March 31, 2019 | | | 774,840 | |
March 31, 2020 | | | 595,159 | |
Thereafter | | $ | 2,521,059 | |
|
| | | | Weighted- | | Weighted-Average | | |
| | | | Average Exercise | | Remaining | | |
Options | | Shares | | Price | | Contractual Term | | |
Options Outstanding April 1, 2013 | | 4,092,500 | | $ | 0.87 | | 2.29 | |
Granted | | 706,250 | | | 0.36 | | | |
Exercised | | | | | | | | |
Expired/Cancelled | | (456,250) | | | 0.73 | | | |
Options Outstanding March 31, 2014 | | 4,342,500 | | $ | 0.77 | | 1.75 | |
Granted | | | | | | | | |
Exercised | | | | | | | | |
Expired/cancelled | | (4,110,000) | | | 0.79 | | | |
Options Outstanding March 31, 2015 | | 232,500 | | $ | 0.35 | | 1.45 | |
Exercisable at March 31, 2015 | | 23,125 | | $ | 0.44 | | 1.20 | |
| | | | Weighted Average | | |
| | | | Grant-Date | | |
Non-vested Shares | | Shares | | Fair Value | | |
Non-vested at April 1, 2013 | | 2,466,167 | | $ | 0.65 | |
Granted | | 706,250 | | | 0.22 | |
Vested | | (575,625) | | | 0.45 | |
Expired/cancelled: non-vested | | (182,000) | | | 0.38 | |
Non-vested at March 31, 2014 | | 2,414,792 | | | 0.49 | |
Granted | | | | | | |
Vested | | (122,000) | | | 0.43 | |
Expired/cancelled: non-vested | | (2,083,417) | | | 0.52 | |
Non-vested at March 31, 2015 | | 209,375 | | $ | 0.21 | |
| | | Options Outstanding | | Options Exercisable | | ||||||||
Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (years) | | Weighted Average Exercise Price | | Number of Shares | | Weighted Average Exercise Price | | |||
$ | 0.80 | | 7,500 | | 0.27 | | $ | 0.80 | | 5,500 | | $ | 0.80 | |
$ | 0.33 | | 225,000 | | 1.49 | | | 0.33 | | 17,625 | | | 0.33 | |
| | | 232,500 | | 1.45 | | $ | 0.35 | | 23,125 | | $ | 0.44 | |
|
2016 | | $ | 407,410 | |
2017 | | | 361,660 | |
2018 | | | 224,410 | |
2019 | | | 224,410 | |
2020 | | | | |
2021 and thereafter | | $ | | |
|
| | At March 31, | | At March 31, | | ||
| | 2015 | | 2014 | | ||
Accrued expenses | | $ | 194,165 | | $ | 235,998 | |
Property and equipment | | | (185,992) | | | (150,810) | |
Impairment of fixed assets | | | 299,537 | | | 142,767 | |
Capitalized startup/acquisition costs | | | 461,636 | | | 499,288 | |
Federal and state net operating loss carry-forward | | | 5,344,982 | | | 3,857,269 | |
Intangible assets | | | 59,849 | | | 14,537 | |
| | $ | 6,174,177 | | $ | 4,599,049 | |
| | | | | | | |
Valuation allowance | | | (6,174,177) | | | (4,599,049) | |
Total | | $ | | | $ | | |
| | At March 31, 2015 | | | At March 31, 2014 | | ||||||
| | Amount | | % | | | Amount | | % | | ||
Tax at statutory federal income tax rate | | $ | (1,408,162) | | (34.0) | % | | $ | (1,683,324) | | (34.0) | % |
Increase (decrease) resulting from: | | | | | | | | | | | | |
State income tax expense | | | | | 0.0 | % | | | | | 0.0 | % |
Change in valuation allowance | | | 1,406,400 | | 34.0 | % | | | 1,671,941 | | 33.8 | % |
Incentive stock options | | | | | 0.0 | % | | | | | 0.0 | % |
Other, net | | | 1,762 | | 0.0 | % | | | 11,383 | | 0.2 | % |
| | | | | | | | | | | | |
Total | | $ | | | 0.0 | % | | $ | | | 0.0 | % |
|
Balance of ownership interest in joint venture at December 18, 2014 | | $ | 1,000 | |
Aggregate fiscal 2014 equity gain share of joint venture income | | | 29,041 | |
Balance of ownership interest in joint venture at March 31, 2015 | | $ | 30,041 | |
| | | | |
Cumulative recognized income on ownership interest in joint venture at March 31, 2015 | | $ | 29,041 | |
Revenues | | $ | 124,908 | |
Expenses | | | 66,825 | |
Net Income | | $ | 58,083 | |
| | | | |
Total Assets | | $ | 551,405 | |
| | | | |
Total Liabilities | | $ | 491,322 | |
Total Partners Capital | | | 60,083 | |
Total Liabilities and Partner Capital | | $ | 551,405 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|